ClinicalTrials.Veeva

Menu

Follow-up Study of ICUS and CCUS Patients

S

Soochow University

Status

Invitation-only

Conditions

Myelodysplastic Syndromes

Treatments

Other: Observation and necessary supportive care

Study type

Observational

Funder types

Other

Identifiers

NCT04428489
SZcytopenia01

Details and patient eligibility

About

The proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions has been released by an international consensus group. Based on the criteria, patients with persistent cytopenia could be diagnosed with MDS, CCUS and ICUS. However, the process and outcome of pre-MDS conditions (CCUS, ICUS) is still to be characterized in Chinese population. We design this prospective observational study to explore the disease process and outcome in ICUS and CCUS patients.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with cytopenia of any degree in one or more lineages: erythrocytes, neutrophils, or platelets. And the cytopenia has to be persistent (≥ 4 months) and lacking minimal diagnostic criteria of MDS.

Exclusion criteria

  • Patients with cytopenia which could be explained by any other hematologic or non-hematologic disease.

Trial design

300 participants in 2 patient groups

Idiopathic cytopenia of undetermined significance (ICUS)
Treatment:
Other: Observation and necessary supportive care
Clonal cytopenia of unknown significance (CCUS)
Treatment:
Other: Observation and necessary supportive care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems